The North Atlantic Treaty Organization has selected companies from more than 20 countries to participate in its global Defence Innovation Accelerator’s 2026 Challenge Programme.
NATO’s Defence Innovation Accelerator, known as DIANA, connects companies with military end-users, mentors, and investors accelerating the development, validation, and adoption of innovations to help NATO tackle operational challenges and maintain an edge in defence technology.
Selected innovators will participate in DIANA’s Accelerator Programme to
develop dual-use technologies that address critical defence and security challenges, according to a statement from NATO, including advanced communications and contested electromagnetic environments, autonomy and unmanned systems, energy and power, biotech and human resilience, and infrastructure and logistics.
“DIANA’s mission is to find the most innovative companies, help them advance their solutions and grow their business, and get the technologies we need into the hands of NATO operators,” says James Appathurai, who is serving as Interim Managing Director of NATO DIANA.
“Over the next year, these innovators will accelerate breakthrough technologies that can help to transform how the Alliance defends against current and emerging threats,” Appathurai stated.
Several companies from Canada were selected for the Defence Innovation Accelerator, including a few based in British Columbia, such as Squamish’s FireSwarm, Victoria’s Niricson, Surrey’s Hydrogen in Motion, and Vancouver’s Lux Bio and Avivo Biomedical.
“Being selected by NATO DIANA’s Challenge Programme from a record 3,680 submissions across the Alliance reinforces the growing need for autonomous systems that improve operational readiness and response in the toughest environments and conditions,” suggests Alex Deslauriers, cofounder and chief executive officer of FireSwarm.
FireSwarm, a Foresight 50 firm and finalist for Company of the Year at the BC Tech Technology Impact Awards, is developing autonomous drone swarms that can suppress wildfires around the clock.
NATO DIANA’s tap of Avivo similarly “validates universal blood as a strategic capability, not just a scientific advance,” according to CEO John Coleman.
His company is working on medical miracles, such as the ability to convert donor kidneys.
“As a Vancouver-based Canadian biotech, we’re proud that our ECO-Blood platform is being recognized as essential to modernizing field transfusions and strengthening global medical readiness,” Coleman remarked.
“Access to NATO’s defence network will accelerate our ability to bring universal blood into real-world, operational models,” the CEO stated.
NATO’s recognition of Avivo “demonstrates the global impact of Canadian biotechnology,” according to Dr. Stephen Withers, a University of British Columbia professor emeritus.
Avivo’s work, says Withers, “proves that Canada is producing technologies with the power to strengthen both humanitarian and defence outcomes worldwide.”
Leave a Reply